Inspire Medical Systems (INSP) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
27.3mn → 29.8mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
steady at 4.2% of revenue (−1.6% YoY).
$175.0M returned vs $78.5M of FCF in FY25. The gap comes off the balance sheet (see net cash).
16¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Over this window: gross 85.7% → 85.4%. Net margin 15.9% is more than double the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 880,936.0 | 911,981.0 | 802,804.0 | 624,799.0 | 407,856.0 | 233,394.0 | ▲13.6% | +40.6% |
Cost of revenue | 121,701.0 | 133,225.0 | 122,986.0 | 96,576.0 | 66,115.0 | 33,279.0 | ▲8.3% | +41.5% |
Gross profit | 759,235.0 | 778,756.0 | 679,818.0 | 528,223.0 | 341,741.0 | 200,115.0 | ▲14.6% | +40.5% |
Research & development | 97,642.0 | 103,165.0 | 114,128.0 | 116,536.0 | 68,645.0 | 37,350.0 | ▼9.6% | +28.9% |
Selling, general & admin | 645,830.0 | 624,637.0 | 529,607.0 | 451,958.0 | 320,688.0 | 202,615.0 | ▲17.9% | +32.5% |
Total operating expenses | 743,472.0 | 727,802.0 | 643,735.0 | 568,494.0 | 389,333.0 | 239,965.0 | ▲13.1% | +32.0% |
Operating incomefeeds ROC rank | 15,763.0 | 50,954.0 | 36,083.0 | −40,271.0 | −47,592.0 | −39,850.0 | ▲41.2% | — |
Other income, net | 15,058.0 | 14,743.0 | 22,370.0 | 20,365.0 | 3,324.0 | −2,120.0 | — | — |
Pretax income | 30,821.0 | 65,697.0 | 58,453.0 | −19,906.0 | −44,268.0 | −41,970.0 | ▲12.4% | — |
Income tax | −69,895.0 | −79,725.0 | 4,944.0 | 1,247.0 | 613.0 | 72.0 | — | — |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 100,716.0 | 145,422.0 | 53,509.0 | −21,153.0 | −44,881.0 | −42,042.0 | ▲171.8% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 3.35 | 4.89 | 1.75 | −0.72 | −1.60 | −1.54 | ▲179.4% | — |
Diluted shares (mn) | 28.93 | 29.76 | 30.54 | 29.30 | 28.07 | 27.26 | ▼2.6% | +2.2% |
| Margins | ||||||||
Gross margin80th pct in Healthcare | 86.2% | 85.4% | 84.7% | 84.5% | 83.8% | 85.7% | ▲0.7pp | −0.3pp |
Operating margin | 1.8% | 5.6% | 4.5% | −6.4% | −11.7% | −17.1% | ▲1.1pp | +22.7pp |
Net margin71st pct in Healthcare | 11.4% | 15.9% | 6.7% | −3.4% | −11.0% | −18.0% | ▲9.3pp | +34.0pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Inspire Medical Systems' revenue last fiscal year?
Inspire Medical Systems reported revenue of $912.0M in fiscal 2025, up 13.6% from fiscal 2024.
What was Inspire Medical Systems' net income?
Inspire Medical Systems reported net income of $145.4M in fiscal 2025, a net margin of 15.9%.

